Arrowshare Ventures

Arrowshare Ventures is a small Austin-based VC operating opportunistically across multiple verticals, with stated exposure to bio and healthcare alongside consumer, crypto, enterprise software, gaming, and fintech. The fund is reported at roughly $10.5M AUM, placing it firmly in the micro-VC category where check sizes are small and selectivity within any single vertical is therefore high.

The stated approach is co-investment across opportunistic positions rather than a thematic deep-dive into any single sector. For digital health founders, this means Arrowshare is realistic only as a participation investor in a syndicate already led by another firm, not as a thematic anchor. The disclosed portfolio includes Bolt, Taboola, Uptime Charger, Groq, and Zum, which read more as enterprise, consumer, and infrastructure positions than as concentrated healthcare exposure. Founders should accordingly treat the healthcare label as opportunistic and ask directly about the firm’s actual digital health book during initial conversations.

Disclosed check size is $250K to $1M, deployed at seed, Series A, and Series B. Geographic scope spans the United States, Estonia, and Nigeria, which is unusually broad for a fund of this size and reflects an opportunistic posture. This is a small co-investor, not a lead.

The disclosed team member is Raphael Hakeem, listed as Founder. Founders should approach Raphael directly through LinkedIn or a warm introduction.

Approach Arrowshare when you have a credible lead investor on a seed or Series A round, the round has open allocation, and you want an additional small check from an Austin-based co-investor with a broad portfolio. They are not the right call as a lead, as a healthcare-specialist underwriter, or as a primary signal investor for a digital health round. The right entry is a warm introduction from a portfolio founder or from an Austin-ecosystem operator who knows Raphael directly. When pitching, keep the ask scoped to a small co-investment slot, lead with the existing lead investor and the round structure, and avoid framing Arrowshare as a healthcare-thesis investor. Founders with concentrated healthcare-only investor needs should target dedicated digital health funds first and treat Arrowshare as an opportunistic add-on.